The case for three times weekly dosing Once you reach steady state (typically after 5 to 6 weeks of daily dosing), blood levels of semaglutide remain relatively stable even with less frequent dosing
They are especially promising given their long duration of action, decreased risk of hypoglycemia, and added benefit of weight loss
These reactions occur because of the injection process itself and the body's response to the copper peptide solution
The higher-dose semaglutide formulation for obesity (Wegovy, 2.4 mg weekly) can produce 10-15% weight loss, while diabetes doses typically yield more modest reductions
Research Grant Support- Intercept, Galectin, BMS, Novo Nordisk, Viking, Pfizer
Medical Review This pages scientific content was reviewed for accuracy on 2026-07-28 By Dr